• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China’s Coronavirus Emergency Response for Urgently Needed Medical Devices

China’s Coronavirus Emergency Response for Urgently Needed Medical Devices

Thursday, 12 March 2020 / Published in Medical Device, News

China’s Coronavirus Emergency Response for Urgently Needed Medical Devices

Since the Coronavirus outbreak, the prevention and control work were deployed as the top priority of the China government at all levels. Due to the urgent demand of overseas medical products, the registration process was expedited to follow the Emergency Examine and Approval Procedure for Medical Device (No.565-2009) that was officially released in August 2009 by the State Food and Drug Administration (former NMPA).

According to the Procedure, the registration approval can be received as soon as five days and the registration tests will be carried out within 24 hours after receiving the samples. Once the registration application is accepted, the technical review and the administrative approval will be completed by the food and drug administrative departments within a time period subjected to the classification of the medical devices as listed in the table below:

The number of institutions are listed with the respective testing capability in the table below:

Medical Device

Technical ReviewAdministrative Approval

Class I

5 Days

Class II

5 Days3 Days

Class III

10 Days3 Days

During the past two months, medical products were urgently approved through the expedited process to help control the epidemic situation.

26.01.2020 – 4 Novel Coronavirus Detection products were urgently approved

28.01.2020 – 2 Nucleic Acid Detection Reagents were urgently approved

31.01.2020 – 1 Nucleic Acid Detection Reagents were urgently approved

05.02.2020 – An accumulated total of 72 medical products were urgently approved.

07.02.2020 – The urgent approval of medical protective clothing was announced

12.02.2020 – Important notes for the technical approval of Nucleic Acid Detection were announced

24.02.2020 – An accumulated total of 339 medical products and 7 Nucleic Acid Detection Reagents were urgently approved

11.03.2020 – An accumulated total of 10 Nucleic Acid Detection Reagents and 6 Antibody Detection Reagents were urgently approved

As of 05.03.2020, the CAME (China Association of Medical Equipment), a business unit under the China’s Ministry of Health, released 4 batches of urgently needed medical devices and IVDs for Coronavirus prevention and treatment, and approximately 25% of the products were produced by foreign manufacturers.

During this critical period, overseas medical products are considered to bring higher standards and innovative technologies for epidemic prevention in China. Due to this great demand, foreign manufacturers are encouraged by the Chinese government to enter the market.

Tagged under: Emergency Examine and Approval Procedure for Medical Device, medical device

What you can read next

Reformation for Production Licenses and SAMR announces Brake Pad Products for CCC Certification
China cross border data transfer for medical devices
China issues new measures on cross border data transfer security assessments for medical devices
New Clinical Trial Exemption List

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.